Analyst Ratings for Orchestra BioMed Inc. (OBIO)
OBIO Rating Summary
OBIO Price Target Summary
- Highest: $20.00 (Chardan)
- Lowest: $9.00 (Jefferies)
- Average: $13.14
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$13.14 (+229.4%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
Avg. $ Target:
$13.14 (+229.4%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/10/2025 | TD Cowen | Joshua Jennings | New Coverage | Buy (N/A) |
15.00 (N/A) |
4.20 (3.99) |
-5% | Details |
| 8/20/2025 | BTIG » Updated 3/13/2026 |
Marie Thibault | Downgrade | Neutral (Buy) |
N/A (N/A) |
2.55 (3.99) |
56.47% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


